Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05588609
Phase: Phase 2
Trial Summary: This is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients with the following di – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Merus N.V.
Acronym:

Pin It on Pinterest